In conclusion, changing the membrane free cholesterol content alters the function and localization of both NTCP and OCT1, suggesting that individuals with liver conditions like NAFLD and NASH have impaired transporter capacities. Here, SLC10A1 is linked to metabolic dysfunction-associated steatotic liver disease.